BCYC
Bicycle Therapeutics plc
NASDAQ · GBHealthcareBiotechnology
$4.16-1.19%
Price as of Jul 20, 2026
BCYC valuation
Bicycle Therapeutics plc valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 21.81x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.52x
- Price / sales
- 4.57x
- Price / cash flow
- -1.27x
Enterprise value
- Enterprise value
- -$253.7M
- EV / sales
- -4.00x
- EV / EBITDA
- 1.20x
- EV / EBIT
- 1.05x
- Market cap
- $290.4M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.